Labcorp Introduces FDA-Cleared Rapid Fentanyl Test for Emergency Use
Labcorp has launched the first FDA-cleared rapid fentanyl test manufactured in the United States, designed to deliver results in just 10 minutes. This test, known as the Labcorp Fentanyl Urine Visual Test, is intended for use in emergency departments, hospitals, and clinics to quickly identify fentanyl exposure. The test detects norfentanyl, the primary metabolite of fentanyl, which remains in urine for up to 48 hours after exposure, providing a longer detection window than fentanyl itself. The test is available through Labcorp Point of Care, previously known as MEDTOX Diagnostics, and is cleared for use by qualified professionals in Clinical Laboratory Improvement Amendments (CLIA)-certified settings. Labcorp emphasizes the importance of rapid and reliable screening tools in emergency care, especially as synthetic opioids like fentanyl become more prevalent. 
